Business Wire

STARWOOD-HOTELS

Del
Sheraton Hotels & Resorts Continues Global Revitalisation with the Re-Opening of the Sheraton Mallorca Arabella Golf Hotel

Starwood Hotels & Resorts Worldwide, Inc. (NYSE:HOT) announced today that its global powerhouse, Sheraton Hotels & Resorts, continues to enhance its portfolio with the re-opening of the Sheraton Mallorca Arabella Golf Hotel following a complete nine-month, multi-million Euro renovation. This renovation is part of a multi-year revitalisation of the Sheraton brand through which Starwood and its owner partners have invested more than US$6 billion. Sheraton now stands stronger than ever with the most robust portfolio in its history and is experiencing record-breaking growth, putting the brand on track to open its 500th hotel in 2015.

“Together with Schörghuber Corporate Group, our owner partner with whom we have had a relationship for over 15 years, Starwood is committed to the continued development of the tourism industry in Mallorca,” commented Michael Wale, President, Starwood Hotels & Resorts, Europe, Africa and Middle East. “The revitalisation of Sheraton Mallorca Arabella Golf Hotel allows us to meet the increased demand for high-calibre accommodation with distinctive guest experiences, providing golf enthusiasts, global travellers, as well as the local community with an inviting gathering place for all occasions.”

“We have spent the last few years renovating and rebuilding of the hotel industry’s most iconic brands and Sheraton’s all-time high guest satisfaction scores are a direct result of this investment,” said Hoyt Harper, Global Brand Leader, Sheraton Hotels & Resorts. “The newly renovated Sheraton Mallorca Arabella Golf Hotel – the Sheraton brand’s only golf-inclusive resort in Europe – demonstrates our commitment to making the brand an unparalleled leader in the hospitality sector.”

Sheraton Mallorca Arabella Golf Hotel
A gathering place for golfers, business and leisure travellers, as well as the local community, Sheraton Mallorca Arabella Golf Hotel offers a vibrant, open atmosphere with relaxing views of the golf green and surrounding Mediterranean garden. The hotel comprises 93 elegant guests rooms, including 23 suites, all equipped with the signature all-white Sheraton Sweet Sleeper™ Bed. The refurbished rooms feature a harmonious blend of contemporary design with a warm palette, as well as large terrace doors that open onto views of the garden, pool or golf course.

A short drive away from Palma de Mallorca and within the prestigious villa district of Son Vida, the golf-inclusive hotel is owned by Arabella Hospitality Group. The hotel is located next to the 18th hole of the Arabella Golf Course Son Vida – and offers guests free play at 63 holes on four courses (Son Vida, Son Muntaner, Son Quint and Son Quint Pitch & Putt) alongside complimentary shuttle transfers from the hotel.

The hotel introduced Shine Spa for Sheraton , offering a lively yet relaxing spa experience after a day of golf and sun in Mallorca. The spa comprises four treatment rooms, a new indoor pool, sauna and steam bath, a 24-hour fitness pavilion, and guests can choose from an extensive menu of facial and body treatments using products from Germaine de Capuccini and Phytomer. Other facilities at the hotel include a fitness pavilion with the latest power and cardio equipment, two outdoor pools, two tennis courts, as well as a kids’ club with its own pool and playground.

At Es Carbó restaurant, guests can enjoy healthy Sheraton breakfast selections and Mediterranean-inspired cuisine alongside views of the golf green. Bodega del Green serves Spanish classics, tapas and wines within its cosy interiors featuring Andalusian touches. Located in the lobby, Bar 18+Uno is a convivial meeting place and venue for Sheraton Social Hour , where management bring guests together to socialise over a glass of wine several times weekly.

Inside the spacious new lobby, guests have complimentary wireless internet access with the signature Link@Sheraton SM experienced with Microsoft® – a social, technology hub where guests can stay connected to what matters most during their stay.

Starwood in Spain
Starwood currently operates 17 hotels and resorts throughout Spain under seven of its nine distinct lifestyle brands. In addition to Sheraton Mallorca Arabella Golf Hotel, the popular Spanish holiday island is also home to The St. Regis Mardavall Mallorca Resort and Castillo Hotel Son Vida, a Luxury Collection Hotel . Other Starwood hotels in Spain include the ground-breaking W Barcelona , the venerable Westin Palace in Madrid, Le Méridien Ra Beach Hotel & Spa , as well as recently restored Hotel Alfonso XIII, a Luxury Collection Hotel, Seville and Hotel Maria Cristina, a Luxury Collection Hotel, San Sebastian .

For more information on Sheraton Mallorca Arabella Golf Hotel, please visit www.sheraton.com/mallorca .

No. No. No.

About Sheraton Hotels & Resorts
Sheraton helps guests make connections at more than 400 hotels in 70 countries around the world and recently completed a $6 billion global revitalization and is now in the midst of an $8 billion global expansion over the next three years. Sheraton is owned by and is the largest and most global brand of Starwood Hotels & Resorts Worldwide, Inc., one of the leading hotel and leisure companies in the world with 1,162 properties in nearly 100 countries and 171,000 employees at its owned and managed properties. Starwood is a fully integrated owner, operator and franchisor of hotels, resorts and residences with the following internationally renowned brands: St. Regis® , The Luxury Collection® , W® , Westin® , Le Méridien® , Sheraton® , Four Points® by Sheraton, Aloft® and Element SM . The Company boasts one of the industry’s leading loyalty programs, Starwood Preferred Guest (SPG), allowing members to earn and redeem points for room stays, room upgrades and flights, with no blackout dates. Starwood also owns Starwood Vacation Ownership, Inc., a premier provider of world-class vacation experiences through villa-style resorts and privileged access to Starwood brands. For more information, please visit www.starwoodhotels.com .

Contact:

Press contact:
Jenni Benzaquen, Tel. +32 2 204 5494
Director Public Relations – Europe, Africa & Middle East
Starwood Hotels & Resorts
Jenni.Benzaquen@starwoodhotels.com
www.starwoodmediacentre.com

Link:

Multimedia Gallery

ClickThru

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

FDA Grants Priority Review for Zoliflodacin New Drug Application for the Treatment of Uncomplicated Gonorrhea and Assigns Target PDUFA Date of December 15, 202512.6.2025 13:00:00 CEST | Press release

FDA is expected to notify Innoviva Specialty Therapeutics regarding its decision to conduct an Advisory Committee Meeting in the Day 74 letterIf approved, zoliflodacin would be the first new antibiotic for treating gonorrhea in decades Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. (NASDAQ: INVA), in collaboration with the Global Antibiotic Research & Development Partnership (GARDP), today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review for the New Drug Application (NDA) for zoliflodacin, an investigational first-in-class, single dose, spiropyrimidinetrione oral antibiotic for the treatment of uncomplicated gonorrhea in adults and pediatric patients 12 years and older. The FDA assigned a target action date of December 15, 2025 under the Prescription Drug User-Fee Act (PDUFA). It is expected the FDA will notify Innoviva Specialty Therapeutics regarding the FDA’s decision to conduct an Advisory Committee Meeting in the Day 74

Supply Chain Leaders to Share Perspective on Tackling Tariffs, Trade, and Disruption During Exclusive Digital Event12.6.2025 13:00:00 CEST | Press release

Experts from Qualcomm, Viant Medical, and Thermo Fisher Scientific join Kinaxis and economic futurist Andrew Busch to share insights on navigating tariff volatility As global trade tensions remain at the forefront of business decision-making,Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain orchestration, will host technology and life sciences supply chain leaders for a special tariff-focused digital event with economic futurist Andrew Busch on June 17, 2025 at 11:00am eastern. Titled, Tariffs, Trade, and Turbulence: How to Respond to Today’s Supply Chain Challenges, the event is tailored for global business leaders and will offer expert insights on how to navigate today’s volatile trade environment with modern supply chain solutions to build resilient, future-ready supply chains. “We’re witnessing a seismic reshaping of global trade dynamics with leaders needing to decode the economic and geopolitical forces behind tariff policy while being able to anticipate what’s comin

BeOne Medicines Showcases Breakthrough Data in CLL and MCL at EHA 202512.6.2025 12:00:00 CEST | Press release

Clinical results from next-generation investigational therapies demonstrate potential for deep, durable responses that support the advancement of pivotal studies and future regulatory filingsPhase 1 study of BCL2 inhibitor sonrotoclax plus BRUKINSA® elicited deep responses – 96% ORR in R/R CLL and 79% ORR in R/R MCL patients – with no new safety signals in the latest resultsBTK degrader BGB-16673 shows strong early results in hard-to-treat populations BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will present new clinical data from three cornerstone hematology assets at the European Hematology Association (EHA) Congress. Four oral presentations highlight the promising clinical activity of BeOne’s next-generation BCL2 inhibitor sonrotoclax, BTK protein degrader BGB-16673, and the backbone of our hematology franchise, BTK inhibitor BRUKINSA (zanubrutinib), which has the broadest label globally of any approved BTK inhibitor. These data reinforce

Infobip Named Among Top 75 in Fortune’s Europe’s Most Innovative Companies 202512.6.2025 10:17:00 CEST | Press release

Fortune ranking aligns with Infobip’s innovative efforts in the IT industry and digital infrastructure Global communications platform Infobiphas been recognized among the top 75 companies in Fortune’s inaugural ranking of Europe’s Most Innovative Companies for 2025. It holds the position of number 68, placing it in the top 25% of all listed companies. This distinction reflects Infobip’s ongoing commitment to advancing Europe’s IT sector and digital infrastructure through cutting-edge innovation. The first Fortune Europe’s Most Innovative Companies list, created in collaboration with Statista, evaluated 300 companies from 21 countries and 16 industries based on innovation culture, product development, and process improvements. Infobip is at the forefront of Europe’s digital transformation. Infobip participates in the IPCEI-CIS project, which aims to build the next-generation global communications platform, thereby reinforcing Europe’s competitiveness in the tech sector. Infobip’s involv

Craig Cook appointed Chief Business Officer and Co-founder at ABILITY Neurotech, the Wyss Geneva’s flagship spin-off12.6.2025 09:00:00 CEST | Press release

The Wyss Center for Bio and Neuroengineering proudly announces the appointment of Craig Cook, former Head of Business Development & Licensing at the Center, as Chief Business Officer and Co-founder of ABILITY Neurotech SA, a pioneering spin-off company translating breakthrough brain-computer interface (BCI) technology into clinical impact. During his tenure at the Wyss Center, Craig Cook played a transformative role in establishing a strong business development framework and positioning the organization as a venture builder in neurotechnology. Under his leadership, six breakthrough technologies were successfully spun out into operational startup companies: Clee Medical SA, Brainscape Medical SA, Dataflight Ltd, BrainQuant SA, Aleos Bio SA, and ABILITY Neurotech SA. In parallel, Craig led the onboarding of aligned startups such as Dandelion Science Corp. and dEEGtal Insights SA, strengthening our AI and neurotech ecosystem. He also contributed to Series A investments in two Wyss-affilia

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye